Caninized Rat Antibodies To Canine Interleukin-31 Receptor Alpha

text
April 21, 2022

Inventors

Mohamad Morsey, Yuanzheng Zhang, Anasuya SAHA

Abstract

The present invention provides caninized rat antibodies to canine IL-31 receptor alpha that have a high binding affinity for canine IL-31 receptor alpha, and that can block the binding of canine IL-31 to canine IL-31 receptor alpha. The present invention further provides the use of the antibodies for the treatment of atopic dermatitis in dogs.

CovalX Technology Used

Epitope Mapping
XL-MS

Source

Contact our Scientific Team to Start the Conversation

Request A Call
Back
Categories : Patents, Epitope Mapping
text
PREVIOUS : Bispecific Binding Molecules Against Vegf and Ang2
NEXT : Plasma and Serum Exosome Markers Analyzed by Matrix-Assisted Laser Desorption/ionization Time-of-flight Mass Spectrometry Coupled with Electron Multiplier
text
CovalX
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.